bromodeoxyuridine has been researched along with Genito-urinary Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hecht, BK; Hecht, F; Lockwood, D; Sandberg, AA; Tajara, EH | 1 |
Matsuyama, H; Sakatoku, J; Shimabukuro, T; Yamamoto, N; Yoshihiro, S | 1 |
Berger, CS; Bixenman, H; Hecht, BK; Hecht, F; Lockwood, D; Sandberg, AA; Tajara, EH | 1 |
3 other study(ies) available for bromodeoxyuridine and Genito-urinary Cancer
Article | Year |
---|---|
New common fragile sites.
Topics: Aphidicolin; Azacitidine; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Chromosome Mapping; Diterpenes; Floxuridine; Genetic Markers; Humans; Lymphocytes; Urogenital Neoplasms | 1988 |
[Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis--study with urogenital tumors].
Topics: Aged; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; Child; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Tumor Cells, Cultured; Urogenital Neoplasms | 1989 |
Fragile sites and genitourinary tumors.
Topics: Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Floxuridine; Genetic Markers; Humans; Lymphocytes; Urogenital Neoplasms | 1988 |